Virginia Board of Pharmacy Ad Hoc Committee to Meet Regarding Documentation Submitted from Registered Nonresident Pharmacies in Response to Recent Compounding Survey

Meeting to Be held on February 1, 2013, at 9:00 a.m.  To view agenda and for location click here

Michigan Introduces Bill Dealing With Pharmacies

SENATE BILL No. 92

January 29, 2013, Introduced by Senators GREEN, JONES, PROOS and HANSEN and referred to the Committee on Health Policy

  A bill to amend 1978 PA 368, entitled

"Public health code,"

by amending sections 16333, 17705, 17707, 17711, 17721, and 17731

(MCL 333.16333, 333.17705, 333.17707, 333.17711, 333.17721, and

333.17731), section 16333 as added by 1993 PA 80, section 17705

as amended by 1986 PA 304, section 17707 as amended by 1990 PA

333, sections 17711 and 17721 as amended by 2006 PA 390, and

section 17731 as amended by 1994 PA 234, and by adding sections

17735, 17736, and 17744a.

THE PEOPLE OF THE STATE OF MICHIGAN ENACT:

 1        Sec. 16333. Fees for a person licensed or seeking licensure

 2  to engage in the practice of pharmacy or other practices

 3  regulated under part 177 are as follows:

College of Veterinary Medicine to host 50th annual conference, alumni weekend | UGA Today

College of Veterinary Medicine to host 50th annual conference, alumni weekend | UGA Today

Dr. Lynn White-Shim of the American Veterinary Medical Association will present the two-hour Georgia laws, ethics and professionalism session on "Compounding: Are You Following the Rules?" for continuing education credit. For those interested in this session only, registration is $40.

Meningitis outbreak just ‘tip of the iceberg,’ ex-fed testifies

January 25, 2013

A former FDA regulator turned compounding pharmacy watchdog told state lawmakers the loosely regulated industry has gone unchecked for too long and warned the deadly nationwide fungal meningitis outbreak linked to Framingham-based New England Compounding Center just scrapes the surface of problems linked to the industry.

“This is one we know about,” Dr. Sarah Sellers told the Herald after her hourlong testimony on Beacon Hill yesterday. “What we don’t know about is even more concerning because most drug-related problems are very difficult to detect, so we’re only getting the tip of the iceberg.”

Sellers alleged the industry operates with huge profit margins but under far less regulation than big pharmaceutical companies.

 

But the industry fired back, saying regulators need to enforce rules already on the books and that major incidents at compounding pharmacies are rare.

“There is no indication that this is an industry that’s out of control,” said Todd Brown of the Massachusetts Independent Pharmacists Association. “This whole thing would have been prevented if the FDA had done their job, enforced their regulations and if the Board of Pharmacy had enforced their regulations.”

A top state health official told the Herald things are changing post-NECC.

“This tragedy has been a wake-up call to all different sectors of that industry and the regulatory arena as well,” said Madeleine Biondolillo of the Bureau of Health Care Safety and Quality. “We’re very confident that between the work we’ve done to inspect the industry and get a lot more information than was ever provided before, we’re going to be increasingly effective.”

State Sen. Mark Montigny (D-New Bedford), who accused the industry of exploiting a lack of regulation it helped create through intense lobbying, said he thinks the aftermath of NECC will make it easier for lawmakers to tighten the rules.

“They’ve already lost the opportunity for constructive feedback,” Montigny said.

 

Source found here